227 related articles for article (PubMed ID: 19654304)
1. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
4. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
5. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.
Ohkura N; Kishi M; Tsukada T; Yamaguchi K
Biochem Biophys Res Commun; 2001 Apr; 282(5):1206-10. PubMed ID: 11302744
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
7. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
8. Menin and its interacting proteins: elucidation of menin function.
Balogh K; Rácz K; Patócs A; Hunyady L
Trends Endocrinol Metab; 2006 Nov; 17(9):357-64. PubMed ID: 16997566
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
[TBL] [Abstract][Full Text] [Related]
10. Stable overexpression of MEN1 suppresses tumorigenicity of RAS.
Kim YS; Burns AL; Goldsmith PK; Heppner C; Park SY; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
Oncogene; 1999 Oct; 18(43):5936-42. PubMed ID: 10557080
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
13. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
14. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
15. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
16. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
[TBL] [Abstract][Full Text] [Related]
17. MEN1 tumor-suppressor protein localizes to telomeres during meiosis.
Suphapeetiporn K; Greally JM; Walpita D; Ashley T; Bale AE
Genes Chromosomes Cancer; 2002 Sep; 35(1):81-5. PubMed ID: 12203793
[TBL] [Abstract][Full Text] [Related]
18. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
20. In search of tumor suppressing functions of menin.
Yang Y; Hua X
Mol Cell Endocrinol; 2007 Feb; 265-266():34-41. PubMed ID: 17222504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
